Evidence map›Paper›PMID 37384075›Full record

ArticleCureus2023

Daptomycin-Induced Pulmonary Toxicity: A Case Series.

Yamini I Patel, Sarasija Natarajan, Srinivasarao Ramakrishna, Pius Ochieng

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Yamini I PatelInternal Medicine, The Wright Center for Graduate Medical Education, Scranton, USA.
Sarasija NatarajanInternal Medicine, The Wright Center for Graduate Medical Education, Scranton, USA.
Srinivasarao RamakrishnaPulmonary and Critical Care Medicine, Geisinger Commonwealth School of Medicine, Scranton, USA.
Pius OchiengPulmonary and Critical Care Medicine, Geisinger Commonwealth School of Medicine, Scranton, USA.
Commonwealth Medical College · USThe Wright Center for Graduate Medical Education · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Daptomycin is a bactericidal antibiotic used to treat methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococcus (VRE). Eosinophilic pneumonia is an uncommon but significant adverse effect of daptomycin. We present two patients treated with daptomycin who subsequently developed eosinophilic pneumonia (EP).

Indexed as

adverse effects of daptomycinantibioticbronchoscopydaptomycindrug induced eosinophilic pneumoniaeosinophiliaeosinphilic pneumoniafeverhypoxiapulmonary toxicity

Identifiers

PMID37384075
PMCPMC10299848
OpenAlexW4378593705

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.